Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age. (Q30364160)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age. |
scientific article |
Statements
1 reference
Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age. (English)
1 reference
Markus Knuf
1 reference
Hans C Rümke
1 reference
Katia Abarca
1 reference
Luis Rivera
1 reference
Maria Lattanzi
1 reference
Paola Pedotti
1 reference
Ashwani Arora
1 reference
Dorothee Kieninger-Baum
1 reference
Giovanni Della Cioppa
1 reference
1 December 2014
1 reference
1 reference
33
1 reference
12
1 reference
e320-9
1 reference
Identifiers
1 reference
1 reference